Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies
Synthetic circular RNA (oRNA) combines nature-driven insights with rational design to produce a bold new class of RNA therapeutics
Therapeutic potential across a broad range of diseases including cancer, autoimmune, and genetic disorders
CAMBRIDGE, M... Biopharmaceuticals, Venture Capital Orna Therapeutics, circular RNA
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Autoimmune Disease | Cancer | Cancer & Oncology | Genetics | Pharmaceuticals | Venture Capital